Download GlobalData’s Covid-19 Executive Briefing report
- ECONOMIC IMPACT -
Latest update: 26 April 2022
GlobalData polls show that concern over the spread of COVID-19 remains volatile, so does the business optimism
Swift development of Covid-19 vaccines and strong capital markets continue to drive Pharma growth; however immediate impact focused on Russia and Ukrainian markets.
The number of confirmed cases in the US exceeds 81 million.
The consensus forecast for world GDP growth in 2022 has been lowered to 3.5%
- SECTOR IMPACT: PHARMA -
Latest update: 4 March 2022
Number of trials that are experiencing delayed initiation, enrollment suspensions or overall slow enrollment
Every aspect of the pharma value chain was impacted by the pandemic, but according to an ongoing GlobalData poll, the biggest impact is in supply chain (35%)
REMOTE PATIENT MONITORING
Remote Patient Monitoring (RPM) tools gained momentum during the start of Covid-19, when the pandemic provided seamless groundwork for effective RPM usage and accelerated technology uptake. While the urgency to implement RPM solutions may have been addressed during the previous year, the adoption of remote monitoring tools will remain solid even after the Covid-19 pandemic recedes, in line with continuous digitalization of the healthcare industry.
RPM was scored as the most impactful industry trend for 2021, but has pushed to the third position, as per the GlobalData’s The State of the Biopharmaceutical Industry Survey, 2022 Edition. Genomics Genomics has been rated as the most impactful industry trend by the surveyed healthcare professionals.